{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T07:46:08Z","timestamp":1781768768737,"version":"3.54.5"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T00:00:00Z","timestamp":1686873600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T00:00:00Z","timestamp":1686873600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Assist Reprod Genet"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s10815-023-02842-8","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T07:02:22Z","timestamp":1686898942000},"page":"1881-1895","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Ultra-low\u2013dose and very-low\u2013dose Lupron downregulation protocols for poor responders based on POSEIDON group 3 and 4 classifications"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9761-8901","authenticated-orcid":false,"given":"Zachary W.","family":"Walker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Lanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serene S.","family":"Srouji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark D.","family":"Hornstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth S.","family":"Ginsburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,16]]},"reference":[{"issue":"2","key":"2842_CR1","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1093\/humupd\/dmz046","volume":"26","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Zhang C, Shu J, et al. Adjuvant treatment strategies in ovarian stimulation for poor responders undergoing IVF: a systematic review and network meta-analysis. Hum Reprod Update. 2020;26(2):247\u201363. https:\/\/doi.org\/10.1093\/humupd\/dmz046.","journal-title":"Hum Reprod Update"},{"issue":"7","key":"2842_CR2","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1093\/humrep\/der092","volume":"26","author":"AP Ferraretti","year":"2011","unstructured":"Ferraretti AP, La Marca A, Fauser BCJM, Tarlatzis B, Nargund G, Gianaroli L. ESHRE consensus on the definition of \u2019poor response to ovarian stimulation for in vitro fertilization: The Bologna criteria. Hum Reprod. 2011;26(7):1616\u201324. https:\/\/doi.org\/10.1093\/humrep\/der092.","journal-title":"Hum Reprod"},{"key":"2842_CR3","doi-asserted-by":"publisher","first-page":"263349412094148","DOI":"10.1177\/2633494120941480","volume":"14","author":"P Drakopoulos","year":"2020","unstructured":"Drakopoulos P, Bardhi E, Boudry L, et al. Update on the management of poor ovarian response in IVF: the shift from Bologna criteria to the Poseidon concept. Ther Adv Reprod Heal. 2020;14:263349412094148. https:\/\/doi.org\/10.1177\/2633494120941480.","journal-title":"Ther Adv Reprod Heal"},{"issue":"1","key":"2842_CR4","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.fertnstert.2017.09.024","volume":"109","author":"A Boza","year":"2018","unstructured":"Boza A, Oguz SY, Misirlioglu S, Yakin K, Urman B. Utilization of the Bologna criteria: a promise unfulfilled? A review of published and unpublished\/ongoing trials. Fertil Steril. 2018;109(1):104-109.e2. https:\/\/doi.org\/10.1016\/j.fertnstert.2017.09.024.","journal-title":"Fertil Steril"},{"issue":"12","key":"2842_CR5","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1093\/humrep\/dew218","volume":"31","author":"G Bozdag","year":"2016","unstructured":"Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-Analysis. Hum Reprod. 2016;31(12):2841\u201355. https:\/\/doi.org\/10.1093\/humrep\/dew218.","journal-title":"Hum Reprod"},{"issue":"9","key":"2842_CR6","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1093\/humrep\/deu135","volume":"29","author":"A Papathanasiou","year":"2014","unstructured":"Papathanasiou A. Implementing the ESHRE \u201cpoor responder\u201d criteria in research studies: methodological implications. Hum Reprod. 2014;29(9):1835\u20138. https:\/\/doi.org\/10.1093\/humrep\/deu135.","journal-title":"Hum Reprod"},{"issue":"6","key":"2842_CR7","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s10815-015-0476-4","volume":"32","author":"A La Marca","year":"2015","unstructured":"La Marca A, Grisendi V, Giulini S, et al. Live birth rates in the different combinations of the Bologna criteria poor ovarian responders: a validation study. J Assist Reprod Genet. 2015;32(6):931\u20137. https:\/\/doi.org\/10.1007\/s10815-015-0476-4.","journal-title":"J Assist Reprod Genet"},{"issue":"6","key":"2842_CR8","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/j.fertnstert.2016.02.005","volume":"105","author":"C Alviggi","year":"2016","unstructured":"Alviggi C, Andersen CY, Buehler K, et al. A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept. Fertil Steril. 2016;105(6):1452\u20133. https:\/\/doi.org\/10.1016\/j.fertnstert.2016.02.005.","journal-title":"Fertil Steril"},{"key":"2842_CR9","doi-asserted-by":"publisher","unstructured":"Roman R, Mussarat N, Detti L. Ovarian stimulation in poor responders: have we made progress? Curr Pharm Biotechnol. 2017;18(8). https:\/\/doi.org\/10.2174\/1389201018666171002132853","DOI":"10.2174\/1389201018666171002132853"},{"issue":"4","key":"2842_CR10","doi-asserted-by":"publisher","first-page":"959","DOI":"10.3906\/sag-1905-179","volume":"49","author":"ZS \u00d6zkan","year":"2019","unstructured":"\u00d6zkan ZS. Ovarian stimulation modalities in poor responders. Turkish J Med Sci. 2019;49(4):959\u201362. https:\/\/doi.org\/10.3906\/sag-1905-179.","journal-title":"Turkish J Med Sci"},{"key":"2842_CR11","doi-asserted-by":"publisher","unstructured":"Montoya-Botero P, Drakopoulos P, Gonz\u00e1lez-Foruria I, Polyzos NP. Fresh and cumulative live birth rates in mild versus conventional stimulation for IVF cycles in poor ovarian responders: a systematic review and meta-analysis. Hum Reprod Open. 2021;2021(1).\u00a0https:\/\/doi.org\/10.1093\/hropen\/hoaa066","DOI":"10.1093\/hropen\/hoaa066"},{"key":"2842_CR12","doi-asserted-by":"publisher","unstructured":"Huang MC, Tzeng SL, Lee CI et al. GnRH agonist long protocol versus GnRH antagonist protocol for various aged patients with diminished ovarian reserve: a retrospective study. PLoS One. 2018;13(11). https:\/\/doi.org\/10.1371\/journal.pone.0207081","DOI":"10.1371\/journal.pone.0207081"},{"key":"2842_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.13933","author":"W Li","year":"2021","unstructured":"Li W, Zhang W, Zhao H, Chu Y, Liu X. Efficacy of the depot gonadotropin-releasing hormone agonist protocol on in vitro fertilization outcomes in young poor ovarian responders from POSEIDON group 3. Int J Gynecol Obstet. 2021. https:\/\/doi.org\/10.1002\/ijgo.13933.","journal-title":"Int J Gynecol Obstet"},{"issue":"4","key":"2842_CR14","doi-asserted-by":"publisher","first-page":"166","DOI":"10.5539\/gjhs.v8n4p166","volume":"8","author":"A Nabati","year":"2015","unstructured":"Nabati A, Peivandi S, Khalilian A, Mirzaeirad S, Hashemi SA. Comparison of GnRh agonist microdose flare up and GnRh antagonist\/letrozole in treatment of poor responder patients in intra cytoplaspic sperm injection: randomized clinical trial. Glob J Health Sci. 2015;8(4):166\u201371. https:\/\/doi.org\/10.5539\/gjhs.v8n4p166.","journal-title":"Glob J Health Sci"},{"issue":"4","key":"2842_CR15","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.fertnstert.2005.04.031","volume":"84","author":"KG Dragisic","year":"2005","unstructured":"Dragisic KG, Davis OK, Fasouliotis SJ, Rosenwaks Z. Use of a luteal estradiol patch and a gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation for in vitro fertilization in poor responders. Fertil Steril. 2005;84(4):1023\u20136. https:\/\/doi.org\/10.1016\/j.fertnstert.2005.04.031.","journal-title":"Fertil Steril"},{"issue":"5","key":"2842_CR16","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1007\/s00404-020-05513-6","volume":"301","author":"X Liu","year":"2020","unstructured":"Liu X, Li T, Wang B, Xiao X, Liang X, Huang R. Mild stimulation protocol vs conventional controlled ovarian stimulation protocol in poor ovarian response patients: a prospective randomized controlled trial. Arch Gynecol Obstet. 2020;301(5):1331\u20139. https:\/\/doi.org\/10.1007\/s00404-020-05513-6.","journal-title":"Arch Gynecol Obstet"},{"issue":"7","key":"2842_CR17","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1093\/oxfordjournals.humrep.a138191","volume":"8","author":"AC Van Steirteghem","year":"1993","unstructured":"Van Steirteghem AC, Liu J, Joris H, et al. Higher success rate by intracytoplasmic sperm injection than by subzonal insemination. report of a second series of 300 consecutive treatment cycles. Hum Reprod. 1993;8(7):1055\u201360. https:\/\/doi.org\/10.1093\/oxfordjournals.humrep.a138191.","journal-title":"Hum Reprod."},{"issue":"3","key":"2842_CR18","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/J.FERTNSTERT.2010.05.042","volume":"94","author":"C Racowsky","year":"2010","unstructured":"Racowsky C, Vernon M, Mayer J, et al. Standardization of grading embryo morphology. Fertil Steril. 2010;94(3):1152\u20133. https:\/\/doi.org\/10.1016\/J.FERTNSTERT.2010.05.042.","journal-title":"Fertil Steril"},{"issue":"11","key":"2842_CR19","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1007\/S10815-019-01580-0","volume":"36","author":"JB Bakkensen","year":"2019","unstructured":"Bakkensen JB, Brady P, Carusi D, Romanski P, Thomas AM, Racowsky C. Association between blastocyst morphology and pregnancy and perinatal outcomes following fresh and cryopreserved embryo transfer. J Assist Reprod Genet. 2019;36(11):2315\u201324. https:\/\/doi.org\/10.1007\/S10815-019-01580-0.","journal-title":"J Assist Reprod Genet"},{"issue":"4","key":"2842_CR20","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/J.FERTNSTERT.2017.01.025","volume":"107","author":"A Penzias","year":"2017","unstructured":"Penzias A, Bendikson K, Butts S, et al. Performing the embryo transfer: a guideline. Fertil Steril. 2017;107(4):882\u201396. https:\/\/doi.org\/10.1016\/J.FERTNSTERT.2017.01.025.","journal-title":"Fertil Steril"},{"issue":"7","key":"2842_CR21","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1023\/A:1016054424966","volume":"19","author":"S Geber","year":"2002","unstructured":"Geber S, Sales L, Sampaio MAC. Comparison between a single dose of goserelin (depot) and multiple daily doses of leuprolide acetate for pituitary suppression in IVF treatment: a clinical endocrinological study of the ovarian response. J Assist Reprod Genet. 2002;19(7):313\u20138. https:\/\/doi.org\/10.1023\/A:1016054424966.","journal-title":"J Assist Reprod Genet"},{"issue":"11","key":"2842_CR22","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1023\/A:1013108921427","volume":"18","author":"JG Franco","year":"2001","unstructured":"Franco JG, Baruffi RLR, Mauri AL, et al. Prospective randomized comparison of ovarian blockade with nafarelin versus leuprolide during ovarian stimulation with recombinant FSH in an ICSI program. J Assist Reprod Genet. 2001;18(11):593\u20137. https:\/\/doi.org\/10.1023\/A:1013108921427.","journal-title":"J Assist Reprod Genet"},{"issue":"1","key":"2842_CR23","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S1028-4559(08)60057-1","volume":"47","author":"YY Hsieh","year":"2008","unstructured":"Hsieh YY, Chang CC, Der TH. Comparisons of different dosages of gonadotropin-releasing hormone (GnRH) antagonist, short-acting form and single, half-dose, long-acting form of GnRH agonist during controlled ovarian hyperstimulation and in vitro fertilization. Taiwan J Obstet Gynecol. 2008;47(1):66\u201374. https:\/\/doi.org\/10.1016\/S1028-4559(08)60057-1.","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"2","key":"2842_CR24","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.fertnstert.2005.09.067","volume":"86","author":"SJ Muasher","year":"2006","unstructured":"Muasher SJ, Abdallah RT, Hubayter ZR. Optimal stimulation protocols for in vitro fertilization. Fertil Steril. 2006;86(2):267\u201373. https:\/\/doi.org\/10.1016\/j.fertnstert.2005.09.067.","journal-title":"Fertil Steril"},{"issue":"3","key":"2842_CR25","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/s0015-0282(16)57443-3","volume":"63","author":"U Sungurtekin","year":"1995","unstructured":"Sungurtekin U, Jansen RPS. Profound luteinizing hormone suppression after stopping the gonadotropin- releasing hormone-agonist leuprolide acetate. Fertil Steril. 1995;63(3):663\u20135. https:\/\/doi.org\/10.1016\/s0015-0282(16)57443-3.","journal-title":"Fertil Steril"},{"issue":"6","key":"2842_CR26","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/S0015-0282(97)81458-6","volume":"67","author":"S Fujii","year":"1997","unstructured":"Fujii S, Kagiya A, Sagara M, Sato S, Kudo H, Saito Y. A prospective randomized comparison between long and discontinuous-long protocols of gonadotropin-releasing hormone agonist for in vitro fertilization. Fertil Steril. 1997;67(6):1166\u20138. https:\/\/doi.org\/10.1016\/S0015-0282(97)81458-6.","journal-title":"Fertil Steril"},{"issue":"7","key":"2842_CR27","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1007\/s10815-021-02185-2","volume":"38","author":"M Cozzolino","year":"2021","unstructured":"Cozzolino M, Cecchino GN, Bosch E, Garcia-Velasco JA, Garrido N. Minimal ovarian stimulation is an alternative to conventional protocols for older women according to Poseidon\u2019s stratification: a retrospective multicenter cohort study. J Assist Reprod Genet. 2021;38(7):1799\u2013807. https:\/\/doi.org\/10.1007\/s10815-021-02185-2.","journal-title":"J Assist Reprod Genet"}],"container-title":["Journal of Assisted Reproduction and Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-023-02842-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10815-023-02842-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-023-02842-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T06:12:54Z","timestamp":1690351974000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10815-023-02842-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,16]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["2842"],"URL":"https:\/\/doi.org\/10.1007\/s10815-023-02842-8","relation":{},"ISSN":["1058-0468","1573-7330"],"issn-type":[{"value":"1058-0468","type":"print"},{"value":"1573-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,16]]},"assertion":[{"value":"21 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"ZW is a contributing author for UptoDate. SS is on the advisory board for Ferring pharmaceuticals. MH is a medical advisory board member for WIN Fertility, Intelon Optics, and contributing author for UpToDate. EG was a medical consultant for Hall-Matson Esq, Teladoc, and CRICO, and is a contributing author for UptoDate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}